MERIDIAN MEDICAL TECHNOLOGIES, LLC

Meridian Medical Technologies, LLC specializes in the design, development, and manufacturing of automated injectors and pharmaceutical countermeasures for high-risk medical scenarios, particularly in defense and public health contexts. Their core expertise lies in the formulation and production of auto-injector systems delivering critical antidotes such as atropine, pralidoxime chloride, and diazepam for nerve agent exposure and chemical threat mitigation. The company demonstrates deep technical proficiency in aseptic pharmaceutical manufacturing, drug-device combination products, and compliance with stringent federal medical supply standards. Their ability to integrate precise dosing mechanisms with stable, single-use delivery platforms positions them as a trusted provider of life-saving emergency medical countermeasures under extreme operational conditions. The contractor maintains a consistent relationship with the Department of Defense and the Department of State, delivering medical countermeasures for military personnel and diplomatic personnel operating in high-threat environments. They also support the Department of Health and Human Services and the Department of Justice with specialized antidote systems, indicating a focus on federal emergency preparedness and law enforcement medical readiness programs. Meridian’s primary industry focus is in pharmaceutical preparation manufacturing (NAICS 325412), with complementary work in medicinal and botanical manufacturing (325411) and surgical appliance manufacturing (339113). This reflects a narrow, high-value specialization in injectable antidotes and their delivery systems, serving the niche but critical market for chemical, biological, radiological, and explosive (CBRNE) medical countermeasures. Based in Saint Louis, Missouri, Meridian Medical Technologies, LLC operates as a small business under the 2L entity structure. While no formal government certifications are listed, their sustained contract performance with federal agencies underscores a proven track record in meeting rigorous quality, regulatory, and supply chain requirements for mission-critical medical devices.